J&J’s Bengay, Sanofi’s Icy Hot May Cause Rare Burns, FDA Says

Johnson & Johnson (JNJ)’s Bengay and Sanofi (SAN)’s Icy Hot are among topical pain relievers that have been associated with a rare risk of serious burns, U.S. regulators said today.

The over-the-counter pain-relieving creams, lotions and patches are linked to 43 cases of burns on the application site, the Food and Drug Administration said in a safety announcement. The cases were identified in a search of the FDA’s adverse event reporting system and medical literature.

The majority of second- and third-degree burns occurred with the use of products containing menthol as the single active ingredient or having both menthol and methyl salicylate, the FDA said. Few cases involved a capsaicin-containing product. Patients who experience pain, swelling or blistering of the skin should stop using the product, the agency said.

“When applied to the skin, the products produce a local sensation of warmth or coolness; they should not cause pain or skin damage,” the FDA said in the announcement.

To contact the reporter on this story: Anna Edney in Washington at aedney@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net

Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.